KALA BIO Future Growth
Future criteria checks 0/6
KALA BIO is forecast to grow earnings and revenue by 25.8% and 61.3% per annum respectively while EPS is expected to grow by 36.4% per annum.
Key information
25.8%
Earnings growth rate
36.4%
EPS growth rate
Biotechs earnings growth | 23.2% |
Revenue growth rate | 61.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 02 Apr 2024 |
Recent future growth updates
Recent updates
Kala Pharmaceuticals to execute reverse stock split
Oct 20Kala Pharmaceuticals Q2 2022 Earnings Preview
Aug 10Staying Patient With Kala Pharmaceuticals
Aug 29The Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Analysts Have Been Trimming Their Sales Forecasts
Aug 10Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?
Jul 07Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?
Apr 05Kala Pharmaceuticals, Inc. (NASDAQ:KALA): When Will It Breakeven?
Mar 08What Kind Of Investors Own Most Of Kala Pharmaceuticals, Inc. (NASDAQ:KALA)?
Feb 15How Many Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Shares Did Insiders Buy, In The Last Year?
Jan 25If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today
Jan 04Kala Pharmaceuticals Should Have Limited Downside With Eysuvis Now Approved
Dec 23The Play On Kala Pharmaceuticals
Dec 17Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt?
Dec 14How Much Did Kala Pharmaceuticals' (NASDAQ:KALA) CEO Pocket Last Year?
Nov 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 25 | -19 | N/A | N/A | 1 |
12/31/2025 | N/A | -42 | N/A | N/A | 1 |
12/31/2024 | N/A | -40 | N/A | N/A | 3 |
12/31/2023 | N/A | -42 | -29 | -28 | N/A |
9/30/2023 | N/A | -46 | -35 | -34 | N/A |
6/30/2023 | 0 | -9 | -47 | -47 | N/A |
3/31/2023 | 3 | -26 | -65 | -65 | N/A |
12/31/2022 | 4 | -45 | -79 | -79 | N/A |
9/30/2022 | 6 | -80 | -93 | -93 | N/A |
6/30/2022 | 8 | -137 | -104 | -103 | N/A |
3/31/2022 | 9 | -145 | -100 | -100 | N/A |
12/31/2021 | 11 | -143 | -109 | -108 | N/A |
9/30/2021 | 12 | -126 | -108 | -106 | N/A |
6/30/2021 | 11 | -126 | -107 | -106 | N/A |
3/31/2021 | 9 | -113 | -105 | -103 | N/A |
12/31/2020 | 6 | -104 | -93 | -91 | N/A |
9/30/2020 | 5 | -95 | -85 | -83 | N/A |
6/30/2020 | 5 | -90 | -82 | -80 | N/A |
3/31/2020 | 6 | -91 | -83 | -81 | N/A |
12/31/2019 | 6 | -94 | -94 | -93 | N/A |
9/30/2019 | 5 | -98 | -93 | -90 | N/A |
6/30/2019 | 3 | -90 | -86 | -84 | N/A |
3/31/2019 | 1 | -81 | -74 | -73 | N/A |
12/31/2018 | N/A | -67 | -56 | -54 | N/A |
9/30/2018 | N/A | -53 | -46 | -45 | N/A |
6/30/2018 | N/A | -47 | -39 | -38 | N/A |
3/31/2018 | N/A | -44 | -38 | -37 | N/A |
12/31/2017 | N/A | -42 | -35 | -34 | N/A |
9/30/2017 | N/A | -39 | N/A | -35 | N/A |
6/30/2017 | N/A | -39 | N/A | -34 | N/A |
3/31/2017 | N/A | -38 | N/A | -32 | N/A |
12/31/2016 | N/A | -33 | N/A | -27 | N/A |
9/30/2016 | N/A | -30 | N/A | -24 | N/A |
6/30/2016 | N/A | -25 | N/A | -19 | N/A |
3/31/2016 | 0 | -18 | N/A | -16 | N/A |
12/31/2015 | 0 | -17 | N/A | -15 | N/A |
9/30/2015 | 0 | -17 | N/A | -16 | N/A |
6/30/2015 | 0 | -17 | N/A | -17 | N/A |
3/31/2015 | 0 | -18 | N/A | -16 | N/A |
12/31/2014 | 0 | -19 | N/A | -15 | N/A |
12/31/2013 | 0 | -11 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KALA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KALA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KALA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KALA is forecast to have no revenue next year.
High Growth Revenue: KALA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KALA's Return on Equity is forecast to be high in 3 years time